利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

110 条记录 (耗时 0.031 秒)

    5-amino-4-hydroxy-7-(imidazo [1,2-A] pyridin-6-ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
    13.
    发明授权
    5-amino-4-hydroxy-7-(imidazo [1,2-A] pyridin-6-ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension 失效
    5-氨基-4-羟基-7-（咪唑并[1,2-A]吡啶-6-基甲基）-8-甲基 - 非酰胺衍生物和相关化合物作为治疗高血压的肾素抑制剂

    公开(公告)号：US08071651B2

    公开(公告)日：2011-12-06

    申请号：US11992132

    申请日：2006-09-14

    申请人： Peter Herold ,  Robert Mah ,  Vincenzo Tschinke ,  Stefan Stutz ,  Aleksandar Stojanovic ,  Christiane Marti ,  Dirk Behnke ,  Stjepan Jelakovic

    发明人： Peter Herold ,  Robert Mah ,  Vincenzo Tschinke ,  Stefan Stutz ,  Aleksandar Stojanovic ,  Christiane Marti ,  Dirk Behnke ,  Stjepan Jelakovic

    IPC分类号： A01N43/42 ,  A01N43/40 ,  A01N43/58 ,  A01N43/00 ,  A01N43/64 ,  A01N37/18 ,  A01N35/00 ,  A01N33/18 ,  A01N33/24 ,  C07C233/00 ,  C07C235/00 ,  C07C237/00 ,  C07C239/00 ,  A61K31/16 ,  A61K31/12

    CPC分类号： C07D405/12 ,  C07D471/04

    摘要： Compounds of the general formula (I) or its salt or a compound in which one or more atoms are replaced by their stable, nonradio-active isotopes, in particular its pharmaceutically acceptable salt; in which X is —CH2—; R is a mono- to tetra-substituted, mono- or bicyclic, unsaturated heterocyclic radical having 1 to 4 nitrogen atoms, R2 is C1-6alkyl or C3-6cycloalkyl; R3 is independently of one another H, C1-6alkyl, C1-6alkoxycarbonyl or C1-6alkanoyl; R4 is C2-6alkenyl, C1-6alkyl, unsubstituted or substituted aryl-C1-6alkyl or C3-8cycloalkyl; R5 is -Lm-R6; L is C1-6alkylene which is optionally substituted by 1-4 halogen, or a linker: formula (II) n=0, 1 or 2; m=0 or 1; R6 is a radical composed of 2 cyclic systems selected from bicyclo[x.y.z]alkyl, spiro[o.p]alkyl, mono- or bioxabicyclo[x.y.z]alkyl or mono- or bioxaspiro[o.p]alkyl, all of which may be substituted by 1-3 substituents selected from C1-6alkyl, C1-6alkoxy, cyano, halogen, C1-6alkoxy-C1-6alkyl, hydroxy-C1-6alkyl or dialkylamino, or if m=0: is also saturated C3-8heterocyclyl which comprises 1-2 oxygen atoms, substituted by 1-3 substituents selected from C1-6alkyl, C1-6alkoxy, cyano, halogen, C1-6alkoxy-C1-6alkyl, hydroxy-C1-6alkyl or dialkylamino, or if m=1: is also saturated C3-8heterocyclyl which comprises 1-2 oxygen atoms, optionally substituted by 1-3 substituents selected from C1-6alkyl, C1-6alkoxy, cyano, halogen, C1-6-alkoxy-C1-6alkyl, hydroxy-C1-6alkyl or dialkylamino; have renin-inhibiting properties and can be used as medicines for the treatment of hypertension.

    摘要翻译： 通式（I）的化合物或其盐或其中一个或多个原子被其稳定的非放射性活性同位素替代的化合物，特别是其药学上可接受的盐; 其中X是-CH 2 - ; R是具有1至4个氮原子的单 - 四取代的单 - 或双环不饱和杂环基，R 2是C 1-6烷基或C 3-6环烷基; R 3彼此独立地为H，C 1-6烷基，C 1-6烷氧基羰基或C 1-6烷酰基; R 4是C 2-6烯基，C 1-6烷基，未取代或取代的芳基-C 1-6烷基或C 3-8环烷基; R5是-Lm-R6; L是任选被1-4个卤素取代的C 1-6亚烷基或连接基：式（II）n = 0,1或2; m = 0或1; R6是由选自双环[xyz]烷基，螺[op]烷基，单或生双环[xyz]烷基或单 - 或生物密封[op]烷基的2个环状体组成的基团，所有这些可以被1- 选自C 1-6烷基，C 1-6烷氧基，氰基，卤素，C 1-6烷氧基-C 1-6烷基，羟基-C 1-6烷基或二烷基氨基的3个取代基，或者如果m = 0：也是饱和的C 3-8杂环基，其包含1-2个氧 原子被1-3个选自C 1-6烷基，C 1-6烷氧基，氰基，卤素，C 1-6烷氧基-C 1-6烷基，羟基-C 1-6烷基或二烷基氨基取代的取代基取代，或者如果m = 1：也是饱和的C 3-8杂环基 其包含1-2个氧原子，任选被1-3个选自C 1-6烷基，C 1-6烷氧基，氰基，卤素，C 1-6 - 烷氧基-C 1-6烷基，羟基-C 1-6烷基或二烷基氨基的取代基取代; 具有肾素抑制性质，可用作治疗高血压的药物。

    Organic compounds
    17.
    发明授权
    Organic compounds 失效
    有机化合物

    公开(公告)号：US08003640B2

    公开(公告)日：2011-08-23

    申请号：US12745100

    申请日：2008-12-04

    申请人： Peter Herold ,  Stjepan Jelakovic ,  Robert Mah ,  Vincenzo Tschinke

    发明人： Peter Herold ,  Stjepan Jelakovic ,  Robert Mah ,  Vincenzo Tschinke

    IPC分类号： C07D413/12 ,  A61K31/538

    CPC分类号： C07D413/12

    摘要： The present invention relates to compounds of the general formula (I) and the salts thereof, preferably the pharmaceutically acceptable salts thereof; in which in which R1 has the meaning explained in the description, a process for their preparation and the use of these compounds as medicines, especially as renin inhibitors.

    摘要翻译： 本发明涉及通式（I）的化合物及其盐，优选其药学上可接受的盐; 其中R1具有说明书中解释的含义，其制备方法和这些化合物用作药物，特别是作为肾素抑制剂。